Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.32 |
| ▸ | CPB1 | P15086 | 1/20 | 0.30 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9717100 | 0.87 | SLC15A2 (0.43) | SLC15A2FOLH1ITGB3ITGA2BCPB1 | |
| SCHEMBL6256586 | 0.84 | GSR (0.34) | ITGB3ITGA2BCPB1CPB2 | |
| SCHEMBL6729163 | 0.80 | ITGB3 (0.41) | SLC15A2ITGB3ITGA2BCPB2 | |
| SCHEMBL9614985 | 0.79 | SLC15A2 (0.38) | SLC15A2 | |
| SCHEMBL5598418 | 0.79 | SLC15A2 (0.64) | SLC15A2FOLH1ITGB3ITGA2B | |
| SCHEMBL3948446 | 0.79 | SLC15A2 (0.59) | SLC15A2FOLH1ITGB3ITGA2B | |
| SCHEMBL3948444 | 0.79 | SLC15A2 (0.59) | SLC15A2FOLH1ITGB3ITGA2B | |
| SCHEMBL259084 | 0.79 | SLC15A2 (0.64) | SLC15A2FOLH1ITGB3ITGA2B | |
| SCHEMBL10595108 | 0.79 | SLC15A2 (0.64) | SLC15A2FOLH1ITGB3ITGA2B | |
| Lysine SCHEMBL28465641 | 0.79 | SLC15A2 (0.48) | SLC15A2ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060258589-A1 | Methods for enhancing radiation therapy | IGF ONCOLOGY, LLC (US) | 2006-11-16 | — | — | US | disclosed |